Javier Cuesta
Overview
Explore the profile of Javier Cuesta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
918
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Rocha-Munoz A, Benito-Villalvilla C, Olivares D, Sirvent S, Garcia-Brenes M, Angelina A, et al.
Allergy
. 2025 Mar;
PMID: 40052502
Background: A causal relationship between Crohn's disease (CD) and asthma is reported, but the underlying mechanisms are not fully understood. We sought to investigate the role of IgE and IgE-mediated...
2.
Marschall A, Rivero F, Bastante T, Del Val D, Cuesta J, Alfonso F
Coron Artery Dis
. 2024 Dec;
36(1):84-85.
PMID: 39648931
No abstract available.
3.
Alfonso F, Shaburishvili T, Farah B, Gogorishvili I, Monsegu J, Baranauskas A, et al.
Coron Artery Dis
. 2024 Nov;
36(2):91-98.
PMID: 39601687
Background: Treatment of patients with in-stent restenosis (ISR) remains challenging. In this setting the use of drug-coated balloons (DCB) represents an attractive approach to avoid adding another metal layer to...
4.
Del Val D, Marschall A, Bastante T, Rivero F, Cuesta J, Alfonso F
JACC Cardiovasc Interv
. 2024 Oct;
17(20):2441-2442.
PMID: 39477648
No abstract available.
5.
Marschall A, Rivero F, Bastante T, Cuesta J, Del Val D, Sarnago F, et al.
JACC Case Rep
. 2024 Aug;
29(15):102422.
PMID: 39157563
Heterotopic bicaval stenting offers an alternative therapeutic approach for indirectly addressing the systemic effects of tricuspid regurgitation (TR) in patients with severe symptomatic TR, despite optimal medical therapy. In this...
6.
Cuesta J, Perez-Vizcayno M, Garcia Del Blanco B, Bosa F, de Prado A, Rumoroso J, et al.
JACC Cardiovasc Interv
. 2024 Aug;
17(15):1825-1836.
PMID: 39142758
Background: In patients with in-stent restenosis (ISR) bioresorbable vascular scaffolds (BVS) provide similar results to drug-coated balloons (DCBs) but are inferior to drug-eluting stents (DES) at 1 year. However, the...
7.
Del Val D, Berta B, Roleder T, Malinowski K, Bastante T, Hermanides R, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Aug;
26(1):38-48.
PMID: 39138849
Aims: To evaluate the individual as well as combined impact of optical coherence tomography-detected vulnerability features (OCT-VFs) in the prediction of major adverse cardiovascular events (MACEs) in non-ischaemic lesions in...
8.
Del Val D, Berta B, Roleder T, Malinowski K, Bastante T, Hermanides R, et al.
EuroIntervention
. 2024 Jun;
20(11):e707-e717.
PMID: 38840580
Background: Thin-cap fibroatheroma (TCFA) lesions are associated with a high risk of future major adverse cardiovascular events. However, the impact of other optical coherence tomography-detected vulnerability features (OCT-VFs) and their...
9.
Marschall A, Rivero F, Del Val D, Bastante T, Cuesta J, Alfonso F
JACC Case Rep
. 2024 Jan;
28:102122.
PMID: 38204557
Calcified nodules (CNs) represent the least common cause of acute coronary syndrome. Furthermore, case reports describing CNs as the underlying cause for ST-segment elevation myocardial infarction are exceptional. We present...
10.
Rivero F, Roquero P, Cuesta J, Bastante T, Del Val D, Aguilar R, et al.
JACC Cardiovasc Interv
. 2023 Aug;
16(17):2191-2193.
PMID: 37565967
No abstract available.